Thirty-Day Readmissions after Transcatheter Aortic Valve Replacement in the United States: Insights from the Nationwide Readmissions Database

  • Dhaval Kolte
  • , Sahil Khera
  • , M. Rizwan Sardar
  • , Neil Gheewala
  • , Tanush Gupta
  • , Saurav Chatterjee
  • , Andrew Goldsweig
  • , Wilbert S. Aronow
  • , Gregg C. Fonarow
  • , Deepak L. Bhatt
  • , Adam B. Greenbaum
  • , Paul C. Gordon
  • , Barry Sharaf
  • , J. Dawn Abbott

Research output: Contribution to journalArticlepeer-review

139 Scopus citations

Abstract

Background - Readmissions after cardiac procedures are common and contribute to increased healthcare utilization and costs. Data on 30-day readmissions after transcatheter aortic valve replacement (TAVR) are limited. Methods and Results - Patients undergoing TAVR (International Classification of Diseases-Ninth Revision-CM codes 35.05 and 35.06) between January and November 2013 who survived the index hospitalization were identified in the Nationwide Readmissions Database. Incidence, predictors, causes, and costs of 30-day readmissions were analyzed. Of 12 221 TAVR patients, 2188 (17.9%) were readmitted within 30 days. Length of stay >5 days during index hospitalization (hazard ratio [HR], 1.47; 95% confidence interval [CI], 1.24-1.73), acute kidney injury (HR, 1.23; 95% CI, 1.05-1.44), >4 Elixhauser comorbidities (HR, 1.22; 95% CI, 1.03-1.46), transapical TAVR (HR, 1.21; 95% CI, 1.05-1.39), chronic kidney disease (HR, 1.20; 95% CI, 1.04-1.39), chronic lung disease (HR, 1.16; 95% CI, 1.01-1.34), and discharge to skilled nursing facility (HR, 1.16; 95% CI, 1.01-1.34) were independent predictors of 30-day readmission. Readmissions were because of noncardiac causes in 61.8% of cases and because of cardiac causes in 38.2% of cases. Respiratory (14.7%), infections (12.8%), bleeding (7.6%), and peripheral vascular disease (4.3%) were the most common noncardiac causes, whereas heart failure (22.5%) and arrhythmias (6.6%) were the most common cardiac causes of readmission. Median length of stay and cost of readmissions were 4 days (interquartile range, 2-7 days) and $8302 (interquartile range, $5229-16 021), respectively. Conclusions - Thirty-day readmissions after TAVR are frequent and are related to baseline comorbidities, TAVR access site, and post-procedure complications. Awareness of these predictors can help identify and target high-risk patients for interventions to reduce readmissions and costs.

Original languageEnglish
Article numbere004472
JournalCirculation: Cardiovascular Interventions
Volume10
Issue number1
DOIs
StatePublished - 1 Jan 2017
Externally publishedYes

Keywords

  • aortic stenosis
  • costs and cost analysis
  • length of stay
  • readmission
  • rehospitalization
  • transcatheter aortic valve implantation
  • transcatheter aortic valve replacement

Fingerprint

Dive into the research topics of 'Thirty-Day Readmissions after Transcatheter Aortic Valve Replacement in the United States: Insights from the Nationwide Readmissions Database'. Together they form a unique fingerprint.

Cite this